Further explore whether there were age-related gene or gene sets in stage I-III and HoR+/HER2- breast cancer, and the results showed that there were no differentially expressed genes between 20–40 years and 41–60 years groups, which suggested that young age breast cancer is not a unique biological entity. Here, ERBB2 is linked to breast carcinoma.